Intuitive Surgical (NASDAQ:ISRG) Earns Hold (C) Rating from Weiss Ratings

Intuitive Surgical (NASDAQ:ISRG)‘s stock had its “hold (c)” rating reaffirmed by research analysts at Weiss Ratings in a research report issued to clients and investors on Friday,Weiss Ratings reports.

ISRG has been the subject of a number of other reports. The Goldman Sachs Group raised their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Rothschild & Co Redburn raised their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $534.28 on Friday. The company’s fifty day simple moving average is $464.32 and its two-hundred day simple moving average is $498.61. Intuitive Surgical has a 1 year low of $425.00 and a 1 year high of $616.00. The stock has a market capitalization of $191.53 billion, a price-to-earnings ratio of 70.67, a PEG ratio of 4.94 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the business earned $1.84 earnings per share. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. Equities research analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Buying and Selling

In related news, Director Craig H. Barratt sold 2,193 shares of the company’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $548.01, for a total value of $1,201,785.93. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 96,011 shares of company stock valued at $50,309,042 in the last three months. 0.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently made changes to their positions in the business. Norway Savings Bank increased its position in Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after purchasing an additional 910 shares during the period. IronOak Wealth LLC. purchased a new stake in Intuitive Surgical in the second quarter worth about $1,099,000. Trust Co. of Oklahoma purchased a new stake in Intuitive Surgical during the 2nd quarter valued at about $363,000. Amalgamated Bank grew its position in Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after purchasing an additional 1,772 shares during the last quarter. Finally, Neville Rodie & Shaw Inc. grew its position in Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after purchasing an additional 1,110 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.